Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
about
GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitisThe kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel diseaseThe C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiationDiagnostic imaging advances in murine models of colitis.Murine models of inflammatory bowel disease (IBD): challenges of modeling human diseaseDextran sodium sulphate colitis mouse model: traps and tricksFucoidan Extracts Ameliorate Acute ColitisOligomannan Prebiotic Attenuates Immunological, Clinical and Behavioral Symptoms in Mouse Model of Inflammatory Bowel Disease.Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiotaUridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in MiceSIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis.Doenjang prepared with mixed starter cultures attenuates azoxymethane and dextran sulfate sodium-induced colitis-associated colon carcinogenesis in mice.Tumor necrosis factor alpha and inflammation disrupt the polarity complex in intestinal epithelial cells by a posttranslational mechanismNew perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation.Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA.Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory moleculesLongitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice.Matriptase protects against experimental colitis and promotes intestinal barrier recoveryPharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced ColitisAcute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice.Oral administration of fermented wild ginseng ameliorates DSS-induced acute colitis by inhibiting NF-κB signaling and protects intestinal epithelial barrierInhibitory effects of meju prepared with mixed starter cultures on azoxymethane and dextran sulfate sodium-induced colon carcinogenesis in mice.Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model.β7-Integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon.Ginseng Berry Extract Attenuates Dextran Sodium Sulfate-Induced Acute and Chronic Colitis.The Involvement of Ca(2+) Signal Pathways in Distal Colonic Myocytes in a Rat Model of Dextran Sulfate Sodium-induced Colitis.Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis.Cardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine.Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators.Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitisInhibitory effects of resistant starch (RS3) as a carrier for stachyose on dextran sulfate sodium-induced ulcerative colitis in C57BL/6 mice.Inhibitory effects of Dendrobium candidum Wall ex Lindl. on azoxymethane- and dextran sulfate sodium-induced colon carcinogenesis in C57BL/6 mice.Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39+/CD73+ Murine Monocytes Modulate Intestinal Inflammation via Induction of Regulatory T Cells.The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.Intestinal inflammation without weight loss decreases bone density and growth.Aryl Hydrocarbon Receptor Activation Down-Regulates IL-7 and Reduces Inflammation in a Mouse Model of DSS-Induced Colitis.Acute severe ulcerative colitis: from pathophysiology to clinical management.Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation.
P2860
Q24313112-5EA8B749-D8A3-41BF-8398-B7E76B635E72Q24339515-FCE62127-9BDE-470E-B64B-6720575859B4Q24620635-492092E3-EC34-48F4-8AAE-103C755E8FD9Q24658452-E3095001-BE9D-4651-A835-B2EABD25B42DQ26774583-D7756206-5A38-4972-B2A6-C950C4C54BF2Q26863622-6CB5B04E-B615-4AD2-B98C-9E6412131D78Q27001084-9FAB2CF2-5A82-4BE7-93AB-645389C0CB61Q27305263-D621B313-527D-4D86-8316-8053E9DBA283Q27342619-15EA7451-55E3-4B7C-A5E0-13E5D0DB3EC5Q28732754-8F8938DD-FBA0-4F6B-AD2F-8E43FE82CCB7Q33819114-A4FD5701-F17B-45FD-B92B-EFA895E23B50Q33968456-32A53B36-27AE-4BB6-8D3E-727327E7964DQ34077338-9B5B927D-F1BA-4B62-B3FE-057F293B7292Q34528504-C8DBE94A-F9A0-4DED-AA80-479476BCE433Q34921594-D5E82E47-978E-4A17-8166-DF8C8B0643A0Q34980263-6045171D-A667-4BD6-8F4B-ED07419714BFQ35047429-8EF6AA15-CC8B-46D1-9DE1-42B9A090ECDEQ35109247-B9100B20-E96C-482B-9DCF-AD43324A6B24Q35785774-E32A055E-8D73-43F9-9262-009181D52B9EQ35895310-AD054947-6AC4-4444-B0FD-F5848541C928Q35913586-B7FBC0AB-E21F-4CDC-A69C-73D5173B9307Q35998545-27118A0C-C809-4DAE-8370-975486F4C5BEQ36079476-B95EDDCB-F46E-4ED7-87DE-2D2065314A80Q36449633-457FCAC0-07BB-465B-A26A-C5B922064A70Q36530839-693A3948-BC8C-4B8C-95E0-C0165E34F70AQ36712469-5A92DC5A-3347-4DC7-8B43-FC6A9309BAF3Q36846255-02FBFECF-50F6-4EC5-A964-B2895CC2E22DQ36930142-6BA75E2F-1B43-4E5B-97D9-A372133E485BQ36949171-693A9141-A918-45A8-B87D-CFEA6466EF18Q37122290-75BCB06B-FE7C-4600-AD9E-958E11FA52E6Q37191009-B4001F20-F031-4EA5-BDDE-3EEAB58A2668Q37262589-C9A37DB3-91F2-4588-A3EF-54BB8CF70DD4Q37288680-32E24821-0765-490A-A1BD-A3B30FAEB767Q37438092-DB0EF888-0BBC-4E23-BC72-1F4A651A944FQ37635119-E25CF0B6-4755-4011-9810-C213233ACF44Q38132555-697AD99D-8283-4C3F-91BD-6949A85450E2Q38812259-F80B8C35-294A-4133-A765-A0C69AE81FD7Q38896238-EEA4634E-4D20-4F0A-BA4C-A8F546BB658EQ38942561-8F2F9084-64F8-4826-8E34-2896200A2B47Q39211576-BE61B5F6-1A5F-4D86-A542-8E10291102EB
P2860
Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Validation of murine dextran s ...... an inflammatory bowel disease.
@en
Validation of murine dextran s ...... an inflammatory bowel disease.
@nl
type
label
Validation of murine dextran s ...... an inflammatory bowel disease.
@en
Validation of murine dextran s ...... an inflammatory bowel disease.
@nl
prefLabel
Validation of murine dextran s ...... an inflammatory bowel disease.
@en
Validation of murine dextran s ...... an inflammatory bowel disease.
@nl
P2093
P1476
Validation of murine dextran s ...... an inflammatory bowel disease.
@en
P2093
Agneta Karlsson
Erik Michaëlsson
Erika Rehnström
Helena Utkovic
Lisa Karlsson
Liselotte Jansson
P304
P356
10.1016/J.INTIMP.2008.01.036
P577
2008-03-07T00:00:00Z